Increased expression of lung resistance-related protein in lower grade urothelial carcinoma of the renal pelvis and ureter

International Journal of Urology

Volumn 11, Issue 9, 2004, Pages 721-727

  Kong, Chui Ze ^a   Zeng, Yu ^a,b   Wu, Xiu Xian ^b   Li, Jia Qing ^b   Zhu, Yu Yan ^a   Chen, Yan ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Lung resistance related protein; Multidrug resistance gene 1; Multidrug resistance associated protein 1; Renal pelvis; Ureter; Urothelial carcinoma

Indexed keywords

LUNG RESISTANCE PROTEIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DOWN REGULATION; EVALUATION; FEMALE; GENE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY PELVIS; MALE; MULTIDRUG RESISTANCE GENE 1; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SAMPLE; STAINING; UPREGULATION; URETER; URINARY TRACT CARCINOMA; UROGENITAL TRACT CANCER; UROTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; DOWN-REGULATION; FEMALE; GENE EXPRESSION; HUMANS; KIDNEY NEOPLASMS; KIDNEY PELVIS; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; RNA, MESSENGER; UP-REGULATION; URETERAL NEOPLASMS; UROTHELIUM; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 6344226369     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2004.00874.x     Document Type: Article

References (28)

1. Kim WJ, Kakehi Y, Hirai M et al. Multidrug resistance-associated protein-mediated multidrug resistance modulated by cyclosporin A in a human bladder cancer cell line. Jpn. J. Cancer Res. 1995; 86: 969-77.
2. Hour TC, Chen J, Huang CY et al. Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines. Anticancer Res. 2000; 20: 3221-5.
3. Motoo Y, Su SB, Nakatani MT et al. Expression of multidrug resistance gene (mdr-1) mRNA in gastric and colorectal cancers. Anticancer Res. 1998; 18: 1903-906.
4. Alexander D, Yamamoto T, Kato S et al. Histopathological assessment of multidrug resistance in gastric cancer: expression of P-glycoprotein, multidrug resistance-associated protein and lung-resistance protein. Surg. Today 1999; 29: 401-406.
5. Pu YS, Tsai TC, Cheng AL et al. Expression of MDR-1 gene in transitional cell carcinoma and its correlation with chemotherapy response. J. Urol. 1996; 156: 271-5.
6. Narasaki F, Matsuo I, Ikuno M et al. Multidrug resistance-associated protein (MRP1) gene expression in human lung cancer. Anticancer Res. 1996; 16: 2079-2082.
7. Fojo AT, Ueda K, Slammon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl Acad. Sci. USA 1987; 84: 265-9.
8. Cole SP, Bhardwaj G, Gerlach JH et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992; 258: 1650-54.
9. Scheffer GL, Wijngaard PLG, Flens MJ et al. The drug resistance-related protein LRP is the vault protein. Nature. Med. 1995; 1: 578-2.
10. Kong LB, Siva AC, Rome LH, Stewart PL. Structure of the vault, a ubiquitous cellular component. Structure 1999; 7: 371-9.
11. Uematsu T, Yamaoka M, Doto R, Tanaka H, Matsuura T, Furusawa K. Expression of ATP-binding cassette transporter in human salivary ducts. Arch. Oral Biol. 2003; 48: 87-90.
12. Izquierdo MA, Shoemaker RH, Flens MJ et al. Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines. Int. J. Cancer 1996; 65: 230-7.
13. Raaijmakers HG, Izquierdo MA, Lokhorst HM et al. Lung resistance-related protein expression is a negative predictive factor for response to conventional low but not to intensified dose alkylating chemotherapy in multiple myeloma. Blood 1998; 91: 1029-36.
14. Eble JN, Sauter G, Epstein JI, Sesterhenn IA. 2004. Pathology and genetics of tumours of the urinary system and male genital organs, IARC Press, Lyon.
15. Komdeur R, Plaat BEC, van der Graaf WTA et al. Expression of multidrug resistance proteins, P-gp, MRP1 and LRP, in soft tissue sarcomas analysed according to their histological type and grade. Eur. J. Cancer 2003; 39: 909-916.
16. Clifford SC, Neal DE, Lunec J. Alterations in expression of the multidrug resistance-associated protein (MRP1) gene in high-grade transitional cell carcinoma of the bladder. Br. J. Cancer 1996; 73: 659-66.
17. Young LC, Campling BG, Voskoglou-Nomikos T et al. Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response. Clin. Cancer Res. 1999; 5: 673-80.
18. Kim WJ, Kakehi Y, Yoshida O. Multifactorial involvement of multidrug resistance-associated protein, DNA topoisomerase II and glutathione/glutathione- S-transferase in non P-glycoprotein-mediated multidrug resistance in human bladder cancer cells. Int. J. Urol. 1997; 4: 583-90.
19. Kim WJ, Kakehi Y, Wu WJ, Fukumoto M, Yoshida O. Expression of multidrug resistance-related genes in urothelial cancer. Br. J. Urol. 1996; 78: 361-8.
20. Atsulo K, Masakazu Y, Kenyaro N et al. Expression of multidrug resistance-related transporters in human breast carcinoma. Jpn. J. Cancer Res. 2001; 92: 452-8.
21. Carter A, Dann EJ, Katz T et al. Cells from chronic myelogenous leukaemia patients at presentation exhibit multidrug resistance not mediated by either MDR1 or MRP1. Br. J. Haematol. 2001; 114: 581-90.
22. Kitazono M, Okumura H, Ikeda R et al. Reversal of LRP associated drug resistance in colon carcinoma SW-620 cells. Int. J. Cancer 2001; 91: 126-31.
23. Klunder JW, Komdeur R, van der Graaf WTA et al. Expression of multidrug resistance-associated proteins in rhabdomyosarcomas before and after chemotherapy: The relationship between lung resistance-related protein (LRP) and differentiation. Hum. Pathol. 2003; 34: 150-55.
24. List AF, Spier CS, Grogan TM et al. Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia. Blood 1996; 87: 2464-9.
25. Lollini PL, De Giovanni C, del Re B et al. Myogenic differentiation of human rhabdomyosarcoma cells induced in vitro by antineoplastic drugs. Cancer Res. 1989; 49: 3631-6.
26. Marchal JA, Prados J, Melguizo C et al. Actinomycin D treatment leads to differentiation and inhibits proliferation in rhabdomyosarcoma cells. J. Laboratory Clin. Med. 1997; 130: 42-50.
27. Kitazono M, Sumizawa T, Takebayashi Y et al. Multi-drug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells. J. Natl. Cancer Inst. 1999; 91: 1647-53.
28. Izquierdo MA, Scheffer GL, Flens MJ et al. Broad distribution of the multidrug resistance-related vault lung resistance in normal human tissues and tumors. Am. J. Pathol. 1996; 148: 877-87.